PATIENTS » CANCER TYPES » LEUKEMIAS » ACUTE LYMPHOID LEUKEMIA

Facebook YouTube Pennhealth Care Pages
Resources

Learn More

Acute Lymphoid Leukemia

Adult Acute Lymphoid (lymphoblastic) leukemia (ALL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).

Different treatments are available for those with acute lymphoblastic leukemia (ALL). Some treatments are called standard. This means they are the currently used treatments. Some treatments are being tested in clinical trials. A treatment clinical trial is a study meant to help improve current treatments or obtain information on new treatments.

When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. You may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment, while others are available during or after treatment.

Treatment options vary depending on your situation including the stage of the cancer and other...

The Abramson Cancer Center hosts a wide range of materials and activities that provide education and support to address key areas of concern for cancer patients and their loved ones. We are proud that many of our innovative patient education programs have been recognized by national groups, including the National Cancer Institute's Cancer Patient Education Network.

Our educational materials and support activities help people deal with the physical and emotional consequences of a cancer diagnosis and treatment. They also assist patients and families to resume active lives after treatment.

Our support group meetings provide information on topics of ...

The Abramson Cancer Center of the University of Pennsylvania is committed to helping each cancer survivor find ways to enjoy life to the fullest. We have a nationally recognized program that focuses on the issues that survivors face, called "Living Well After Cancer™."

The LIVESTRONG™ Survivorship Center of Excellence, The Living Well After Cancer Program (LWAC) at the Abramson Cancer Center, directed by Linda A. Jacobs, PhD, RN, is a clinical, research, and education effort focused on early intervention and prevention of disease as the ultimate goal.

The multidisciplinary LWAC Program currently provides care and research opportunities to cancer survivors treated at Penn, the University of Pennsylvania Cancer Network hospitals, and through the Living Well After ...
Survivor Stories

Karen Nicholas
With the help of her medical team at the Abramson Cancer Center, Karen Nicholas has conquered the challenges of cancer.


News

Wasted Breath: National Health Strategy Misses Chance to Create Network for Acute Lung Cancer

Cells of Aggressive Leukemia Hijack Normal Protein to Grow, According to Penn Study

Penn Researchers Find Genetic Link to Leukemias with an Unknown Origin

Glaxo Gets FDA Approval for Leukemia Drug

Novartis Highlights Leukemia Drug Tasigna

Spotlight

Focus On Blood Cancers and Bone Marrow Transplant Video
A patient education video with testimonies from our patients, doctors and researchers. Find out more about programs, treatment, research and care that is unique to the Abramson Cancer Center.

Carl June, MD on Patient Power tv discusses Research on the Horizon for Hematologic Malignancies

Alan Gewirtz, MD on Patient Power tv discusses Research on the Horizon for Hematologic Malignancies

OncoLink Podcast

5th Annual Focus on Leukemia, Lymphoma and Myeloma Patient Education Conference - click here to view podcasts, photos, and more

Dr. Schuster speaks at ASH: Updates in Lymphoma Research

Dan Vogl speaks live from ASH: Updates on the Treatment of Multiple Myeloma

Dr. Loren speaks at ASH 2008: Breaking News in Chronic Myelogenous Leukemia (CML)



Leukemia/Myelodysplastic Syndrome Trials

A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With... more